RNA Advisors supports life sciences and healthcare companies in the planning, preparation, and diligence stages of financings (debt and equity), mergers, acquisitions, and other transactions. We have supported sell-side clients ranging in size from newly formed companies to venture-backed entities to public companies as well as those with an industry sub-sector focus (biotechnology, diagnostics, medical devices, digital health). Our team’s experience working with a broad range of life sciences investors together with our research and financial analysis capabilities give us useful insights into how counterparties may react during the process based on our extensive experience with like transactions.
